Principal Investigator | Institute of Materia Medica, CAMS & PUMC | China
Dr. Weishuo Fang is a pharmacology researcher specializing in medicinal chemistry, drug discovery, and molecular therapeutics. His work focuses on FXR modulators, neuroprotection, and anticancer drug development. With 1694 citations, 102 publications, and an h-index of 24, he has made significant contributions to translational and pharmaceutical research.
Citation Metrics
1800
1500
1200
900
600
300
0
View Scopus Profile View ORCID Profile View Google Scholar Profile
Featured Publications
Farnesoid X receptor modulator represses liver fibrosis via ERK/p38 signaling pathways
– Toxicology Mechanisms and Methods, 2024
Modulation of taxane binding to tubulin improves microtubule targeting and anticancer activity
– European Journal of Medicinal Chemistry, 2023
Structure optimization of FXR modulators for NASH therapy
– Pharmaceuticals, 2023
Discovery of selective FXR modulators improving metabolic disorders
– Bioorganic Chemistry, 2022
Neuroprotective compound reducing amyloid-related cytotoxicity
– Neurochemical Research, 2020